<DOC>
	<DOCNO>NCT00744055</DOCNO>
	<brief_summary>Prazosin alpha-1 adrenergic receptor antagonist use successfully treatment trauma nightmare sleep disturbance combat veteran PTSD , alcohol dependence . The objective study evaluate efficacy prazosin ( 16mg ) versus placebo reduce alcohol consumption decrease symptom PTSD patient comorbid AD PTSD .</brief_summary>
	<brief_title>Prazosin Treatment Patients With Alcohol Dependence ( AD ) Post Traumatic Stress Disorder ( PTSD ) .</brief_title>
	<detailed_description>Background : There high rate comorbidity alcohol dependence ( AD ) post traumatic stress disorder ( PTSD ) . The rate PTSD among individual AD least twice high general population . In addition , alcohol dependence common comorbid condition men PTSD . Despite , little known best treat individual comorbid AD PTSD . The use alpha-1 adrenergic receptor antagonist represent novel approach treatment may target symptom AD PTSD . There evidence common neurobiological mechanism underlie AD PTSD . Prazosin alpha-1 adrenergic receptor antagonist use successfully treatment trauma nightmare sleep disturbance combat veteran PTSD , alcohol dependence . Objective : The objective study evaluate efficacy prazosin ( 16mg ) versus placebo reduce alcohol consumption decrease symptom PTSD patient comorbid AD PTSD . Methods : Thirty participant current diagnosis AD PTSD enrol 13-week trial . They assign , double-blind fashion , either prazosin placebo . Significance : This project first compare prazosin placebo effective treatment reduce alcohol consumption PTSD symptoms patient AD PTSD .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<criteria>1 . Males female age 2165 year old . 2 . Current alcohol dependence , determine structured clinical interview ( Structured Clinical Interview DSMIV Axis I Disorders ) ( SCID ) ( First et al . 1996 ) . 3 . Current PTSD determine Clinician Administered PTSD Scale DSMIV ( CAPS ) ( Blake et al . 1995 ) . 4 . Patients current alcohol dependence , least one recent episode heavy drinking ( defined 5 drink per drinking episode ) past 14 day . 5 . Medically neurologically healthy basis history , physical examination , EKG , screen laboratory ( CBC w/ differential , TSH , FreeT4 , ASAT , ALAT , GGT , BUN , creatinine , calcium , phosphorous , magnesium , total protein , albumin , electrolytes , VDRL , urinalysis , betaHCG ) . 6 . For woman , negative pregnancy test use acceptable method contraception . 1 . Females pregnant lactating . 2 . Individuals current unstable medical condition neurological , cardiovascular , endocrine , renal , liver , thyroid pathology ( LFT 5 time normal , abnormal BUN creatinine , unmanaged hypertension BP 200/120 ) opinion physician would preclude patient fully cooperate potential harm course study . 3 . Patients meet current SCID criterion follow major Axis I diagnose ( Bipolar Disorders , Schizophrenia Schizophreniatype Disorders ) . 4 . History substance dependence ( alcohol , cocaine , tobacco cannabis ) DSMIV criterion last 30 day . 5 . Individuals take mood stabilizer antipsychotic medication . 6 . Individuals history sensitivity quinazolines prazosin . 7 . Individuals take medication think influence alcohol consumption ( naltrexone , disulfiram , acamprosate ) . 8 . Individuals take adrenergic medication ( e.g . clonidine ) . 9 . Agents may interact prazosin drug CNS depressant effect include tizanidine xyrem .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>alcohol dependence</keyword>
	<keyword>post traumatic stress disorder</keyword>
	<keyword>treatment</keyword>
	<keyword>prazosin</keyword>
</DOC>